Back

Revascularisation is primarily intended for chronic coronary syndrome patients with symptoms refractory to medical therapy: con.

27 August 2021 (12:15 - 12:30)
Organised by:
Congress Presentation Part of: Great Debate: is revascularisation primarily intended for chronic coronary syndrome patients with symptoms refractory to medical therapy? Coronary Artery Disease (Chronic) / Chronic Coronary Syndromes (CCS) ESC Premium Access ESC Congress 2021 - The Digital Experience

About the speaker

Photo
Doctor David Holmes

Mayo Clinic, Rochester (United States of America)

2 More presentations in this session

Presentation thumbnail
Revascularisation is primarily intended for chronic coronary syndrome patients with symptoms refractory to medical therapy: pro.
Doctor R. Al-Lamee (London, GB)
Slides Video
Presentation thumbnail
Great Debate: is revascularisation primarily intended for chronic coronary syndrome patients with symptoms refractory to medical therapy? – discussion.
Video

Access the full session

Session thumbnail
Great Debate: is revascularisation primarily intended for chronic coronary syndrome patients with symptoms refractory to medical therapy?
Video

The Event

Event poster

ESC Congress 2021 - The Digital Experience

27 August 2021 12:15 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources